208110-64-9

Befiradol (NLX-112) is an agonist of 5-HT1A receptor.

Befiradol fumarate is a highly selective and potent 5-HT1A receptor agonist potentially for the treatment of drug-induced dyskinesia in patients with Parkinson's disease.

Befiradol hydrochloride (NLX-112 hydrochloride) 是一种具有选择性的5-羟色胺 1A (5-HT)1A 受体激动剂，具有抗焦虑活性。Befiradol hydrochloride 抑制突变ATXN3聚集。